Doxorubicin (DOX) is an effective and broadly used agent to treat a variety of malignacies, such as leukemias, breast and ovarian cancer, and Hodgkin and non-Hodgkin lymphoma. The major limitation of clinical use is the development of cardiotoxicity. The adverse effects are dose dependent and can vary from transient electrocardiographic abnormalities to cardiomyopathy and heart failure. Recent studies have suggested that the mechanism of DOX-induced cardiotoxicity involves the generation of reactive oxygen species (ROS), especially superoxide anion and hydrogen peroxide.
Although protection or alleviation of DOX toxicity can be achieved by administration of antioxidant vitamins such as ascorbic acid and vitamin E, their cardioprotective effects remain controversial. [8] [9] [10] It is well established that there is no universal "best" antioxidant. For example, ascorbic acid efficiently protects against lipid damage but not against protein damage.
11) Thus alternative naturally occurring antioxidants may potentially be candidates for antioxidant therapy.
It has been shown in many studies that traditionally used plant extracts protect against oxidative damage caused by a wide array of insults including DOX. [12] [13] [14] [15] [16] Among traditional herbs, Phyllanthus spp. (Euphorbiaceae) has been used in Aryuvedic medicine for more than 2000 years and in Thai folk medicine for the treatment of many diseases, such as diarrhea, hepatitis, diabetes, abdominal pain, and kidney disease. 17, 18) The antioxidant effects of plant species in the genus Phyllanthus have been reported. For example, Phyllanthus amarus (synonym: Phyllanthus niruri) reduced oxidative damage from radiation 19) and protected against hepatotoxicity induced by CCl 4 . 20) Phyllanthus emblica protected rat hearts from oxidative stress induced by ischemic-reperfusion injury. 21) Phyllanthus urinaria L. is another medicinal plant that has attracted research attention in the treatment of several diseases. Substantial progress in determining its phytochemical and pharmacologic properties has been made. Several potential antioxidant compounds (e.g., polyphenols, lignans, flavonoids, gallic acid, ellagic acid, etc.) have been isolated from this plant. [22] [23] [24] [25] [26] However, to the best of our knowledge, there has been no report on the potential antioxidant effects of Phyllanthus urinaria. Therefore the purpose of this study was to investigate the antioxidant effects of Phyllanthus urinaria for the protection of cardiac cells from DOX cardiotoxicity.
MATERIALS AND METHODS
Chemicals All chemicals were obtained from SigmaAldrich, St. Louis, MO, U.S.A., unless otherwise indicated. Caspase-3 and NFkB assay kits were purchased from Chemicon International, Inc., Temecula, CA, U.S.A. The catalase activity assay kit was procured from Cayman Chemical, Ann Arbor, MI, U.S.A. Cell culture dishes were obtained from Nalge Nunc International, Rochester, NY, U.S.A. Cell culture media and supplements, were obtained from Gibco Invitrogen, Grand Island, NY, U.S.A.
Plant Material P. urinaria was botanically identified and a specimen voucher was deposited in the Herbarium of the Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Thailand. The aerial part of P. urinaria was dried and ground into powder. The ethanolic extract (PU) was obtained using Soxhlet apparatus (yieldϭ20.3%).
Ferric Reducing/Antioxidant Power Assay The ferric/ antioxidant power (FRAP) assay was performed according to the method described by Benzie and Strain.
27) The standard solutions of FeSO 4 · 7H 2 O (0 to 1000 mM) were used to generate standard curves and the absorbance change (D A) was translated into a FRAP value (in mM). Other antioxidants such as ascorbic acid (VIT C), N-acetylcysteine (NAC, Fluka), and trolox were used for calibration of the FRAP assay. Serial dilutions of PU were obtained from the stock solution (10 mg/ml) and the FRAP value was evaluated based on the standard curve.
Cell Culture and Treatment Protocol Rat H9c2 cardiac myoblasts were acquired from the American Tissue Culture Collection (Manassas, VA, U.S.A.) and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics. Cells were cultured in a 5% CO 2 incubator under a humidified atmosphere at 37°C. Cells were seeded on 96-well plates at 10000 cells/well in DMEM containing 1% FBS, and allowed to attach overnight. The cytoprotective effect of PU was tested by 30-min preincubation (1 or 10 mg/ml) prior to cumulative doses of DOX addition (10 Ϫ9 to 10 Ϫ5 M). Cells were then incubated for 48 h. The antioxidants VIT C (100 mM) and NAC (100 mM) were used for comparison of cytoprotective activity.
Cell Lysates Cell lysates were prepared for the assessment of enzymatic activities and lipid peroxidation. H9c2 cells were grown to confluency in 75-cm 2 flasks. Binding of DOX to proteins was minimized by lowering FBS to a final concentration of 1%. DOX (1 mM) or DOX in combination with PU (1, 10 mg/ml), VIT C (100 mM), or NAC (100 mM) was added to the medium and incubated for 48 h. Cell samples were homogenized in lysis buffer containing Tris buffer 100 mM (pH 7.4), 0.2% Triton X-100, EDTA 1 mM, and 1% protease inhibitor cocktail (Sigma P8340). Cell homogenates were then centrifuged at 10000ϫg for 10 min at 4°C. The clear supernatant was collected for determination of protein concentrations using the Bradford Protein assay kit (BioRad), using bovine serum albumin as a protein standard.
Cytotoxicity Assay H9c2 cytotoxicity was determined using crystal violet method as previously described. 28) Nuclei of live cells were stained with crystal violet dye. Cell survival was quantified as a percentage of the control and the IC 50 values of DOX were determined by fitting the data to a four-parameter logistic equation using GraphPad Prism Software (GraphPad Software, Inc., San Diego, CA, U.S.A.). The cardioprotective effects of PU (IC 50 rightward shifts) were evaluated in comparison with the antioxidants VIT C and NAC.
Lipid Peroxidation Approximately 2ϫ10 6 cells were used per assay. The extent of cellular lipid peroxidation was determined by measuring the concentrations of thiobarbituric acid-reactive substances (TBARS) as described by Menéndez et al. 29) with minor modifications. Briefly, sample oxidation was terminated by adding butylated hydroxytoluene to the final concentration of 10 mM. Malondialdehyde (MDA) solutions (0 to 10 mM) were used to generate standard curve. Standards or samples were incubated with thiobarbituric acid solution containing 0.5% thiobarbituric acid, 6% trichloroacetic acid, and EDTA 1 mM, at 95°C for 90 min. The reaction mixtures were then centrifuged at 9000ϫg for 10 min. The supernatants were removed and the absorbance at 532 nm was measured (Shimadzu UV-1601). TBARS values are expressed as MDA equivalencies (nmol MDA/mg protein).
Caspase-3 Activity This assay is based on spectrophotometric detection of the chromophore p-nitroaniline (pNA). 30) pNA is linked to the end of the caspase-specific substrate. Active caspase cleaves the substrate and releases free pNA. The absorbance was then monitored with a microplate reader (BioRad Model 550). Cell pellets (2ϫ10 6 cells) wer suspended in cold lysis buffer, incubated for 10 min, and centrifuge for 10 min at 10000ϫg. The supernatant was used for the assay and the protein concentration of each sample was adjusted to 50 to 200 mg/50 ml cell lysate. Labeled substrate solution (5 ml) was added and incubated at 37°C for 2 h. The enzyme products were measured by reading the absorbance at 415 nm.
Total Glutathione Determination This assay employs a kinetic enzymatic recycling reaction, based on the oxidation of glutathione (GSH) by 5,5Ј-dithiobis(2-nitrobenzoic acid) (DTNB).
31) The GSH standards or samples were added to the microplate wells, followed by DTNB and GSH reductase. Addition of NADPH to the wells initiated the progressive reduction of DTNB by GSH, causing a color increase that was monitored at 415 nm. The pseudoendpoint mode was used to determine the total GSH (tGSH) concentration.
Catalase Assay The catalase assay utilizes the peroxidation function of catalase for the determination of enzyme activity. This method is based on the reaction of the enzyme with methanol in the presence of an optimal concentration of H 2 O 2 .
The formaldehyde produced was measured spectrophotometrically with the chromogen Purpald (Cayman Chemical). Purpald formed a bicyclic compound with aldehydes, which upon oxidation changes from colorless to purple. The absorbance was read at 550 nm using a BioRad Model 550 plate reader. The assay was performed according to the manufacturer's instructions. Catalase activities are expressed in nmol/min/ml/mg protein.
Superoxide Dismutase Assay Superoxide dismutase (SOD) catalyzes the conversion of superoxide anion radical (O 2 · Ϫ ) to hydrogen peroxide and molecular oxygen. The enzyme activity can be measured based on the dismutation of O 2 · Ϫ generated by non-enzymatic system. 32) Twenty-five microliters of sample or SOD standard (0 to 1000 ng/ml, or 0 to 5.25 units) were pipetted into microplate wells containing 200 ml of freshly prepared reaction mixture (EDTA 0.1 mM, nitro blue tetrazolium (NBT) 62 mM, and NADPH 98 mM in 50 mM phosphate buffer, pH 7.4). The reaction was initiated by the addition of 25 ml of phenazine methosulfate 33 mM in phosphate buffer, pH 7.4, containing EDTA 0.1 mM. After 5-min incubation, the rate of NBT reduction was monitored at 550 nm. Cellular SOD activities are expressed in units of SOD/mg protein.
NFk kB p50/p65 Transcription Factor Assay Nuclear extracts were prepared according to the method described by Andriollo et al. 33) with some modifications. Following trypsinization and PBS washing, cell pellets (ca. 5ϫ10 6 cells, in two T75 culture flasks) were suspended in 250 ml of hypotonic buffer A (HEPES 10 mM, pH 7.9, KCl 10 mM, MgCl 2 1.5 mM, DTT 0.5 mM, 0.1% Triton X-100, 1% protease inhibitor cocktail). Cell suspensions were incubated for 15 min on ice. The cells were then vigorously mixed for 10 s and centrifuged at 4°C, 15000ϫg, for 10 min. The pelleted nuclei were suspended in 2/3 of the original volume in icecold extraction buffer B (HEPES 25 mM, pH 7.9, MgCl 2 1.5 mM, NaCl 0.42 M, EDTA 0.2 mM, DTT 0.5 mM, 1.0% Igepal CA-630, 25% (v/v) glycerol, and 1% protease inhibitor cocktail, and incubated for 30 min on ice, mixed for 10 s, and centrifuged for 10 min at 15000ϫg at 4°C. The supernatants containing nuclear proteins were collected and stored at Ϫ80°C for later use. Protein concentrations are determined using the Bradford protein assay kit (BioRad).
The NFkB transcription assay was performed according to the manufacturer's instructions. Briefly, the capture probe, a double-stranded biotinylated oligonucleotide containing the consensus sequence for NFkB binding (5Ј-GGGACTTTCC-3Ј), was incubated with nuclear extract in transcription buffer. After incubation, the mixture was then transferred to the streptavidin-coated plate. The biotinylated capture probe bound with NFkB protein was immobilized on the plate, and any other unbound materials were washed away. The bound NFkB subunits (p50 and p65) were detected with specific primary antibodies, and the horseradish peroxidase-conjugated secondary antibody was then used for colorimetric detection. The assay also included a positive cell extract, a nonspecific double-stranded oligonucleotide, and a specific competitor double-stranded oligonucleotide as controls.
Statistical Analyses All data are presented as meanϮS.E.M. of at least 3 independent experiments. Statistical significance was determined using t-test or analysis of variance with Bonferroni post-hoc comparison. A value of pϽ0.05 was considered statistically significant.
RESULTS
Total Antioxidant Activity of PU The characteristics of the standard curve (FeSO 4 ) and pure antioxidants used in the FRAP assay were similar to previous study 27) (data not shown). The total antioxidant activity of PU (1 mg/ml) was presented as 5306.75Ϯ461.62 in the FRAP assay (mM). The FRAP value of 1 mg/ml of plant extract was calculated as 0.46 mg/ml VIT C (MW 171.6), based on the constant stoichiometric factor of 2.0 in the FRAP assay. 27) PU Increased the IC 50 Value of DOX Our preliminary studies showed that PU dose-dependently caused cytotoxicity, i.e., 40 to 50% cell death was observed in cells incubated with 100 mg/ml of plant extract (data not shown). Therefore in the present study, we selected the concentrations of 1 and 10 mg/ml at which greater than 80% cell survival was observed. Figure 1 shows the cardioprotective effects of the antioxidants PU, VIT C, and NAC. The IC 50 values of DOX treated with vehicle (CTRL), PU 1 and 10 mg/ml, VIT C (100 mM), and NAC (100 mM) were 0.171Ϯ0.014, 0.481Ϯ 0.068, 1.45Ϯ0.224, 0.569Ϯ0.034, and 0.711Ϯ0.027 mM, respectively. PU dose dependently protected against DOX cardiotoxicity (Fig. 1A) . The significant rightward shifts in the DOX IC 50 value observed with PU (10 mg/ml) treatments were higher (8.5-fold) than those observed in VIT C (100 mM) and NAC treatment (100 mM) (3.3-fold and 4.2-fold, respectively) (Fig. 1B) .
Inhibition of Lipid Peroxidation by PU Table 1 and Fig. 2A show the effects of PU, VIT C, and NAC on lipid peroxidation of cardiac myoblasts. Incubation of H9c2 cells with each antioxidant alone did not change the basal level of the lipid peroxide derivative MDA. In contrast, DOX (1 mM) treatment significantly elevated the MDA content 2.9-fold compared with CTRL (pϽ0.001). VIT C and NAC reduced DOX-induced lipid peroxidation to the basal level. Interestingly, PU extract dose dependently decreased lipid peroxidation to a level lower than the CTRL level (pϽ0.001).
Reduction of Caspase-3 Activity by PU One method to determine cardiac apoptosis is to evaluate the activity of the key enzyme caspase-3. pNA is the product of caspase-3 cleavage and thus reflecting enzyme activity. DOX (1 mM) treatment significantly increased caspase-3 activity (2.3-fold). In the presence of DOX, VIT C and NAC significantly decreased the enzyme activity to the levels higher than CTRL but not significant different from CTRL. On the other hand, H9c2 cell incubation with PU alone dose dependently decreased the enzyme activity (pϽ0.05) and this effect was sustained even in the presence of DOX (Table 1, Fig. 2B ).
Effects of PU on Endogenous Antioxidant Defense tGSH was determined to evaluate the effects of exogenous antioxidants on the cellular GSH reservior. PU treatment alone (1, 10 mg/ml) dose dependently increased the tGSH level in the cardiac myoblasts by 2.13-and 2.69-fold, respectively (Table 1, Fig. 2C ), while VIT C and NAC 100 mM had no significant effect. DOX (1 mM) markedly decreased the tGSH content to 0.05-fold the control level. VIT C but not NAC significantly reversed the DOX effect by restoring tGSH to a level comparable with the CTRL. Despite DOX presence in the culture medium, PU (1, 10 mg/ml) markedly increased tGSH levels to 1.65-and 2.44-fold, respectively, the CTRL level (pϽ0.001).
DOX significantly decreased the endogenous antioxidant enzyme activities of catalase and SOD. PU increased catalase activity both in the presence and absence of DOX. In contrast, VIT C and NAC did not significantly reverse the effects of DOX (Table 1 , Fig. 2D ). Treatment with PU, VIT C, or NAC alone significantly enhanced SOD activity (pϽ0.001), and the effects were sustained even in the presence of DOX except for that of NAC (Table 1, Fig. 2E ).
Antioxidants Inhibit DOX-Induced NFk kB Activation Rel or NFkB proteins are eukaryotic transcription factors involved in the control of many normal cellular processes, such as immune and inflammatory responses, developmental processes, cellular growth, and apoptosis. NFkB commonly refers to p50/p65 (RelA). The p50/p65 heterodimers are the most abundant dimers found in the NFkB signaling pathway. The activity of NFkB is tightly regulated by interaction with DOX (1 mM) significantly activated NFkB by 1.85-fold (pϽ0.05). Treatment with the antioxidants PU (1, 10 mg/ml), VIT C (100 mM), or NAC (100 mM) alone did not significantly change NFkB activity. As shown in Fig. 3 , DOX-induced NFkB activation was abolished by all antioxidants. These results along with those of caspase-3 activity assay reconfirm that NFkB activation is involved in DOX-induced apoptosis.
DISCUSSION
Medicinal plants have long been valued as sources of new compounds with antioxidant activity. Our study demonstrated that PU has high antioxidant capacity relative to other plants with known antioxidant activity, such as Curcuma longa and Morus alba. 34) PU efficiently protected against DOX cardiotoxicity, and the rightward shifts in DOX IC 50 values were more marked than those obtained from pure antioxidants at the concentrations that produced their maximal protective effects in this setting, i.e., VIT C 100 mM and NAC 100 mM.
34)
While most recent studies have focused on the anticancer activity of PU, we are the first to investigate the cardioprotective effects of PU in the hope of concurrently observing its cardioprotective and synergistic antitumor effects in the presence of the anticancer drug DOX. It is well established that antioxidants play a significant role in protecting cells from ROS damage, including exogenous antioxidant activity and the ability to activate or enhance the endogenous antioxidant defense.
H9c2 is a clonal cell line derived from embryonic rat heart tissue and exhibits many of the properties of cardiac muscle, including electrophysiology, ion channels and receptors. [35] [36] [37] Despite not fully differentiated, H9c2 cells have frequently been used as a model of cardiac cells in studies of cardiac hypertrophy, gene expression, and apoptosis. [38] [39] [40] In this study, a low serum level (1%) was used in culture medium during the experiments in order to minimize cell proliferation and stimulate cell differentiation. 41) Thus the effects of PU treatment were not associated with cell proliferation but related to cell survival.
The cardioprotective effects of PU were evaluated by a significant increase in DOX IC 50 values, inhibition of lipid peroxidation, and abrogation of caspase-3 activation induced by DOX. It is well documented that oxidative stress commonly leads to the accumulation of the key cytotoxic lipid peroxide MDA. The cytoprotective effects of antioxidants against DOX is usually associated with the inhibition of lipid peroxidation, regardless of the type and structure of antioxidant. 16, [42] [43] [44] [45] Although the active antioxidants in PU extract have not been identified, its suppression of lipid peroxide formation warrants further investigation.
In addition to the inhibition of lipid peroxidation, the cytoprotective effects of PU as well as of VIT C and NAC may occur in part through the inhibition of DOX-induced caspase-3 activation. Caspase-3 has been identified as a key mediator of apoptosis in mammalian cells. Recent study has revealed that activation of caspase-3 was crucial in DOX-induced apoptosis in nontumor cells. Caspase-3 activation preceded other apoptotic mediators such as p53 in DOX-induced apoptosis in endothelial and cardiac cells, and the opposite occurred in tumor cells.
2) Furthermore, suppression of DOX-induced p53 activation by a p53 inhibitor prevented apoptosis in tumor cell lines but not in endothelial cells and cardiomyocytes. In this study, PU 10 mg/ml alone markedly suppressed caspase-3 activity to levels that lower than in vehicle-treated cells, even in the presence of DOX. In contrast, this effect was not observed with VIT C and NAC treatment. These data suggest that the superior cytoprotective effects of PU compared with VIT C (100 mM) and NAC (100 mM) in this setting may be due in part to the inhibition of caspase-3 activation.
Major intracellular antioxidant defenses are the tGSH pool and ROS-scavenging enzymes such as catalase and SOD. Increased levels or activation of these endogenous antioxidants or enzymes have been shown to protect cells against oxidative damage. For example, the chemoprotective agent, 3H-1,2-dithiole-3-thione protects against DOX-mediated injury in cardiac cells by induction of a battery of cellular antioxidants, including reduced GSH, GSH peroxidase, GSSG reductase, GSH S-transferase (GST), and catalase. 46) Cardioprotective effects were also found due to the overexpressions of GST, CuZn-SOD/Mn-SOD and catalase in both in vitro cardiac gene transfer and in transgenic mice models. [47] [48] [49] Interestingly, PU alone dose dependently increased tGSH, catalase, and SOD activity to levels substantially higher than those of controls and these effects remained in the presence of DOX. On the other hand, the antioxidants VIT C and NAC at the dose used did not similarly enhance tGSH levels and catalase/SOD enzyme activation. The results suggest that PU exerts greater cytoprotective effects (higher degree of DOX IC 50 rightward shifts) than standard antioxidants partially due to these specific properties. Nevertheless, the cytoprotective effects of PU may be mediated in part by activation of NF-E2-related factor 2 (Nrf2), a redox-regulated transcription H9c2 cells were incubated for 48 h with CTRL (vehicle), DOX (1 mM); PU (1 or 10 mg/ml, PU 1 or PU 10, respectively), ascorbic acid (100 mM, VIT C), NAC (100 mM), or combinations of DOX and PU; VIT C or NAC (PU 1ϩDOX, PU 10ϩDOX, VIT CϩDOX, NACϩDOX, respectively). The amount of active NFkB (p50/p65) in treated cells was presented as the absorbance of enzyme product based on enzyme-linked immunosorbent assay as described in Materials and Methods. * Significantly different from CTRL; † significantly different from DOX.
factor that binds to the antioxidant response element (ARE). ARE is a cis-acting enhancer sequence that regulates transcriptional activation of stress-induced genes, including SOD and phase II detoxifying enzymes such as GST and UDPglucuronyltransferase. 50, 51) NFkB is an inducible transcription factor that plays a significant role in regulation of gene transcription associated with both cell survival and apoptosis. It appears that NFkB induces multiple factors to suppress apoptosis at many steps along the cell death cascade including TRAF1 and 2, cIAP1 and 2, caspase-8, and the bcl-2 gene family (Bcl-2 and BclxL). 52, 53) In addition, NFkB can activate the expression of SOD which has been implicated in the potential mechanism of cell survival from ROS. 54, 55) On the other hand, the key determining factors in NFkB death signaling are activation of RIP, TRAF2, FADD, JNK, p38, and ERK.
56) The role of NFkB in cell death is contingent upon the balance of proand antiapoptotic gene products, and the pathways of regulation are cell type and stimulus dependent. Recent studies have shown that NFkB is a key target for ROS, and its activation leads to cell dysfunction and death, particularly in DOXinduced cell death. 2, 57, 58) Like others, this study demonstrated that treatment with antioxidants, including PU, abolished DOX-induced NFkB activation and cardiac cell death.
Although some anticancer agents exert their cytotoxic effects to some extent through the generation of ROS, the use of antioxidants (e.g., ascorbate, vitamin E, b-carotene, plant flavonoids, etc.) for additive or synergistic effects of anticancer activity have long been recognized. 59, 60) The redox homeostasis in cancer vs. normal cells is different and many key components control cellular redox status such as the antioxidant pool and defense. Normal cells are more resistant to a prooxidative shift in the presence of antioxidants, while tumor cells are more susceptible to drug-induced apoptosis in the same milieu. 61) Since PU has both antioxidant and antitumor activities, it is likely that benefit from PU in cancer chemotherapy may be observed but further investigations are needed to confirm this possibility.
In summary, we demonstrated that the cardioprotective effects of PU extract against DOX cardiotoxicity are mediated through multiple pathways. The balance between the survival signals and death signals is crucial in the determination of cell faith. PU enhanced survival factors through elevation of tGSH, activation of catalase/SOD enzyme activity, and inhibition of lipid peroxidation while death signals such as caspase-3 and NFkB activation were suppressed. This study suggests that PU extract may serve as an alternative antioxidant for prevention of DOX cardiotoxicity. Further studies should identify the active constituent(s) of PU for pharmacologic evaluations and potential ROS-related therapeutic implications.
